Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook
Portfolio Pulse from Vandana Singh
Hologic Inc (NASDAQ:HOLX) reported Q3 adjusted EPS of $0.93, down from $0.95 a year ago but beating the consensus of $0.88. Revenue of $984.4 million decreased 1.8% Y/Y, driven by lower sales of COVID-19 assays. However, the company raised its revenue and profit outlook for FY23. Despite this, HOLX shares are down 3.27%.
August 04, 2023 | 10:13 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Hologic's Q3 earnings beat consensus but shares fell due to a dip in revenue. The company raised its FY23 outlook.
Despite beating earnings expectations, Hologic's shares fell due to a decrease in revenue. However, the company raised its FY23 outlook, which could potentially lead to a recovery in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100